MacroGenics, Inc. (MGNX)

MacroGenics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	113.91	57.22	182.84	100.96	108.88	123.47
Short-Term Investments	59.4	132.7	18.83	128.85	45.46	120.15
Cash & Short-Term Investments	173.31	189.91	201.67	229.81	154.35	243.62
Cash Growth	-1.80%	-5.83%	-12.24%	48.89%	-36.64%	-10.61%
Receivables	144.17	13.37	4.31	10.37	56.22	10.39
Inventory	-	7.91	-	1.22	1.45	4.39
Prepaid Expenses	4.21	8.75	11.51	9.95	10.16	21.17
Total Current Assets	321.69	219.94	217.49	251.34	222.18	279.56
Property, Plant & Equipment	23.53	35.52	42.61	45.69	56.91	54.29
Other Long-Term Assets	0.2	1.39	1.56	1.39	1.38	1.4
Total Assets	345.41	256.85	261.66	298.42	280.47	335.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.44	4.79	5.01	6.44	4.9	15.5
Accrued Expenses	29.9	22.23	29.33	24.24	29	33.76
Current Portion of Leases	4.98	5.18	4.86	3.78	4.73	4.68
Current Unearned Revenue	55.5	10.92	16.32	21.65	9.99	20.65
Other Current Liabilities	14.99	-	-	-	-	-
Total Current Liabilities	108.82	43.12	55.53	56.11	48.61	74.58
Long-Term Leases	30.12	31.59	32.6	30.2	30.11	20.79
Long-Term Unearned Revenue	-	55.5	55.5	59.24	59.48	-
Other Long-Term Liabilities	163.61	71.05	1.97	0.26	0.26	0.26
Total Liabilities	302.54	201.26	145.6	145.81	138.46	95.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.64	0.63	0.63	0.62	0.62	0.61
Additional Paid-In Capital	1,304	1,299	1,285	1,255	1,235	1,213
Retained Earnings	-1,262	-1,244	-1,170	-1,103	-1,094	-973.94
Comprehensive Income & Other	-0.02	0.03	0	-0.01	-0.01	-0.06
Shareholders' Equity	42.87	55.59	116.06	152.61	142.01	239.62
Total Liabilities & Equity	345.41	256.85	261.66	298.42	280.47	335.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	35.09	36.76	37.46	33.97	34.83	25.47
Net Cash (Debt)	138.21	153.15	164.21	195.83	119.51	218.15
Net Cash Growth	-0.74%	-6.73%	-16.15%	63.86%	-45.21%	-10.33%
Net Cash Per Share	2.18	2.42	2.62	3.16	1.95	3.64
Filing Date Shares Outstanding	63.7	63.56	63.09	62.43	61.84	61.32
Total Common Shares Outstanding	63.65	63.32	62.82	62.07	61.7	61.31
Working Capital	212.87	176.83	161.96	195.23	173.57	204.98
Book Value Per Share	0.67	0.88	1.85	2.46	2.30	3.91
Tangible Book Value	42.87	55.59	116.06	152.61	142.01	239.62
Tangible Book Value Per Share	0.67	0.88	1.85	2.46	2.30	3.91
Machinery	-	51.73	50.55	50.75	50.73	49.35
Construction In Progress	-	0.37	1.22	1.11	0.36	0.63
Leasehold Improvements	-	45.02	44.1	48.62	52.97	51.06

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error